<DOC>
	<DOCNO>NCT00694148</DOCNO>
	<brief_summary>NT 201 Botulinum toxin type A preparation free complexing protein . Injected muscle , NT 201 cause reversible local relaxation inject muscle . Botulinum toxin type A widely use aesthetic treatment mimic wrinkle . This study investigate safety efficacy NT 201 treatment glabellar frown line .</brief_summary>
	<brief_title>Safety Efficacy NT 201 , Free Complexing Proteins , Treatment Glabellar Frown Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>moderate severe glabellar frown line maximum frown ( ( severity score 2 3 Facial Wrinkle Scale ( FWS ) assess investigator 's rating : 0 = 'none ' , 1 = 'mild ' , 2 = 'moderate ' , 3 = 'severe ' Stable medical condition Age : 18 65 year ( inclusively ) Previous treatment Botulinum toxin serotype upper third part face within last 6 month Previous treatment biodegradable filler glabellar area within last 12 month Previous insertion permanent material glabellar area , include fat graft ( regardless time previous treatment study ) Any surgery glabellar area include surgical removal corrugator , procerus , depressor supercilii muscle combination , scar glabellar area Any plan cosmetic procedure upper third part face trial period Inability substantially lessen glabellar frown line even physically spread apart Marked facial asymmetry ptosis eyelid and/or eyebrow History facial nerve palsy Any infection area injection site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Treatment glabellar frown line</keyword>
</DOC>